Sexual health

NAAT: The Test Doing Most of the Work

Save

Most people have taken a NAAT without knowing the name — the urine cup or self-swab at an STI check is almost always one. This is what nucleic-acid amplification actually does, why it replaced culture for chlamydia and gonorrhea, which samples and sites it accepts, and where its accuracy ends and other kinds of tests begin.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What a NAAT actually is

A NAAT finds an infection by copying its genetic material until there is enough to detect. Instead of trying to grow the organism or catch your body's antibody response, it looks directly for a fragment of the pathogen's DNA or RNA and amplifies that fragment many times over. Even a trace amount of an infection becomes a clear, readable signal.

That is the whole trick, and it is why NAAT is the test doing most of the work in modern STI screening. NAAT stands for nucleic-acid amplification test — a family that includes the PCR tests most people first heard about during the pandemic. Applied to sexual health, the same kind of machinery that copied a virus's genes in a lab is what now finds chlamydia in a cup of urine.

Because it detects genetic material rather than a live, growing organism, a NAAT does not need the bacteria to survive the trip to the lab, and it does not have to wait weeks for antibodies to build up. A NAAT looks for the infection's own genetic fingerprint, which is how it manages to be both fast and extremely sensitive. Those two qualities — speed and sensitivity — are the reason it displaced the tests that came before it.

Why NAAT replaced culture for chlamydia and gonorrhea

For decades, finding chlamydia and gonorrhea meant culturing them — coaxing the bacteria to grow on a plate, which was slow, fussy, and easy to get wrong. Chlamydia in particular is difficult to culture at all, so real infections were routinely missed. NAAT changed that by removing the need for a living organism, and it is considerably more sensitive than culture ever was.

That sensitivity matters most because these infections hide. Chlamydia is frequently 'silent,' causing no symptoms while it can still lead to pelvic inflammatory disease and infertility if it is left untreated 1. A test that only caught symptomatic, easily cultured cases would miss the very infections screening exists to find — the same asymptomatic sti majority that makes routine testing worthwhile in the first place.

Gonorrhea made the case even stronger. It can infect not only the genitals but the rectum and throat, and it is often symptomless in those sites too 2. Culturing gonorrhea from a throat swab is unreliable; amplifying its genetic material is not. The shift to NAAT is a large part of why testing today can be both more accurate and less invasive than it was a generation ago — a better answer from a smaller ask.

What a NAAT can test for

The core of NAAT-based STI testing is the common bacterial infections. Chlamydia and gonorrhea are the two the test was built around, and they remain its highest-volume use by far. A NAAT reports whether the infection's genetic material is present in a given sample — a precise, single question, which is exactly what makes it such a clean screening tool.

The amplification principle is not limited to bacteria. The same method is used to detect viral genetic material as well, which is why nucleic-acid testing is also one of the recognized HIV test types, alongside the antigen/antibody test and the antibody-only test 3. What unites every version is the target: a stretch of the pathogen's own genetic code, copied until it is unmistakable.

What a NAAT does not report is how sick you are. A positive means the genetic material was found in that sample, from that site — not how long you have carried the infection or how much damage it has done. It answers presence, not severity. That narrowness is a feature: a screening test that tried to grade illness would be worse at the one job screening actually needs, which is catching infections that are causing no symptoms at all.

The specimens: urine, swabs, and self-collection

One of NAAT's quiet revolutions is what it will accept as a sample. For genital chlamydia and gonorrhea, a NAAT can run on a urine sample or a swab, which means testing no longer requires an uncomfortable clinician-collected specimen for everyone. For people with a vagina, a vaginal swab is the preferred sample — and it does not have to be collected by a clinician.

Self-collection is not a lesser option. A systematic review found that self-collected vaginal swabs run on NAAT reach roughly 92% sensitivity and 98% specificity compared with clinician-collected samples — accurate enough to support home-based and self-collected screening as a genuine alternative rather than a compromise 4. That evidence is a big part of why at-home sti kits and clinic self-swab programs have expanded so quickly.

The practical effect is that the barrier to getting tested drops. For a lot of people, the difference between testing and not testing is whether the process requires a pelvic exam or a swab someone else has to take. NAAT is the reason it often does not, and the reason a test you collect yourself in a bathroom can be trusted nearly as much as one collected in a clinic.

Testing more than one genital site

Because a NAAT can run on a swab from almost any mucosal surface, it makes site-specific testing possible in a way culture never did well. Gonorrhea and chlamydia can live in the throat and the rectum, frequently with no symptoms, and a urine test checks only the genitals 2. Finding an infection at those sites means sampling those sites — the idea behind a three-site swab that covers the throat, rectum, and genitals for people whose exposures include them.

This is where 'what got tested' matters as much as 'what came back.' A negative urine NAAT is a negative for the genitals and nothing else. Someone with throat or rectal exposure who was tested only by urine has an incomplete answer, however reassuring the result looks on paper. The test is precise, but it reports only on the sample it was actually handed.

Matching the swab to the exposure is not testing more for its own sake. It is closing the gap between where an infection could be and where the sample was taken. NAAT makes that easy to do; it still has to be asked for, because a default panel will not always include the extra sites on its own.

What a NAAT does not replace

A NAAT is powerful, but it is not the whole panel, and treating it as one leaves gaps. HIV is a clear example: the nucleic-acid test is only one of three HIV test types, and everyday HIV screening usually leans on the antigen/antibody test rather than the NAT 3. Syphilis follows its own testing path entirely, which its own page covers — it is not part of the swab-and-urine NAAT most people picture when they think 'STI test.'

Herpes sits outside the NAAT-screening model in a different way. Routine type-specific blood testing for herpes is not recommended for people without symptoms, because a positive antibody result in someone with no history tends to create more confusion than clarity 5. When there is an actual sore, testing the lesion directly is the appropriate step 5 — but that is targeted testing of a symptom, not a screen you add to a panel.

HPV rounds out the boundary. Most HPV infections clear on their own and are never detected, so there is no routine HPV screen for most people the way there is for chlamydia or gonorrhea 6. The lesson is simple: a NAAT answers the questions it was designed for extremely well, and a complete check pairs it with the blood tests and symptom-directed tests it was never built to replace.

When to run a NAAT, and when to repeat it

A NAAT is only as good as its timing. Because it detects the pathogen's genetic material directly, it tends to become positive sooner than an antibody test — but there is still an interval after exposure during which even a NAAT can read falsely negative. The exact number of days varies by infection, and the full grid lives on the sti window periods page. Testing before that window closes is the most common reason an accurate test still gives the wrong answer.

After treatment, a repeat NAAT is sometimes done — not usually to confirm the first treatment worked, but to catch reinfection from a partner who was never treated. And because so many of these infections are silent, testing is driven by exposures and screening intervals rather than by symptoms. Feeling fine is not evidence of being clear; it is the normal state of a great many real infections.

The throat and rectal sites deserve timing thought too, since infections there are especially easy to miss with a symptom-based approach. What the test needs from you is a sample taken from the right place at the right time. Get both right, and a NAAT is about as trustworthy as STI testing gets.

How to read a NAAT result honestly

A NAAT result is highly reliable but not infallible, and its two accuracy numbers explain why. Sensitivity is how often the test catches a real infection; specificity is how often it correctly clears someone who is not infected. Self-collected vaginal swabs, for instance, reach roughly 92% sensitivity and 98% specificity for chlamydia and gonorrhea 4 — high, but not an absolute guarantee in either direction.

That means two things in practice. A negative taken inside the window can still miss an early infection, which is why timing and, when needed, a repeat matter. And a positive is occasionally a false alarm, which is why an unexpected result in someone at genuinely low risk is sometimes confirmed before it is acted on. Neither caveat undermines the test; both simply describe an excellent tool honestly.

The last thing people worry about is usually not accuracy but privacy. Whether a result comes from a NAAT or any other test, how it is recorded and who can see it is a separate system — the ground covered by sti care confidentiality and by what a bill or sti testing on insurance eob actually reveals. The test finds the infection; the paperwork around it runs on its own rules, and is worth understanding in its own right.

Common questions

NAAT stands for nucleic-acid amplification test. It is a molecular test that detects an infection by copying a fragment of the pathogen's DNA or RNA until there is enough to measure. The PCR tests widely used during the pandemic are one type of NAAT. In sexual health, it is the standard, highly sensitive test for chlamydia and gonorrhea, run on urine or a swab.

For most bacterial STIs, yes. A NAAT is more sensitive than culture and does not need a living organism, so it detects infections culture would miss — including chlamydia, which is hard to culture at all. Culture still has specific uses, such as testing a gonorrhea sample for antibiotic resistance, but for routine detection the NAAT has become the standard for good reason.

Yes. Self-collected vaginal swabs run on NAAT reach roughly 92% sensitivity and 98% specificity compared with clinician-collected samples, accurate enough to be a real alternative rather than a fallback. Urine samples and self-swabs are widely accepted for chlamydia and gonorrhea, which is what makes many at-home and clinic self-collection options possible and trustworthy.

No. A NAAT is the standard for chlamydia and gonorrhea, and nucleic-acid testing is one of the HIV test types, but it does not cover everything. Syphilis follows its own testing path, herpes is generally tested only when there is a sore to swab, and most people have no routine HPV screen. A complete check pairs the NAAT with blood tests and symptom-directed tests.

It depends on the infection. Because a NAAT detects genetic material directly, it usually becomes positive sooner than an antibody test, but there is still a window after exposure when even a NAAT can read falsely negative. The exact number of days varies by infection and by the site sampled, so timing the test — and repeating it if it was early — matters.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When testing isn't the whole answer

  • —Fever with severe pelvic or lower-abdominal pain, which can signal pelvic inflammatory disease and needs prompt care rather than waiting on a test
  • —Sudden, severe testicular pain and swelling, which is an urgent problem regardless of any test result
  • —A negative test alongside worsening symptoms, which is a reason to be re-evaluated — an early test can miss a real infection

Severe pelvic or testicular pain, especially with fever, is not something to wait out for a test result — seek same-day care or go to an emergency room.

This article is health education, not medical advice, and does not replace testing and evaluation by a clinician who can choose the right tests for your situation. A NAAT is one tool among several, and a licensed provider interprets it in context.

References

  1. 1.Centers for Disease Control and Prevention (2024). About Chlamydia. CDC (cdc.gov/chlamydia). linkChlamydia is a common, curable bacterial STI that is frequently asymptomatic and can lead to pelvic inflammatory disease and infertility if untreated — the reason a sensitive screening test matters.
  2. 2.Centers for Disease Control and Prevention (2024). About Gonorrhea. CDC (cdc.gov/gonorrhea). linkGonorrhea can infect the genitals, rectum, and throat, is often asymptomatic, and can cause complications if untreated — supporting why site-specific sampling and a sensitive test are needed.
  3. 3.Centers for Disease Control and Prevention (2024). Getting Tested for HIV. CDC (cdc.gov/hiv). linkHIV testing comes in three types — a nucleic-acid test (NAT), an antigen/antibody test, and an antibody test — and everyday screening does not rely on the NAT alone; self-testing options exist.
  4. 4.Lunny C, Taylor D, Hoang L, et al. (2015). Self-Collected versus Clinician-Collected Sampling for Chlamydia and Gonorrhea Screening: A Systematic Review and Meta-Analysis. PLoS One 10(7):e0132776. doi:10.1371/journal.pone.0132776 ✓Self-collected vaginal swabs for chlamydia and gonorrhea NAAT achieve about 92% sensitivity and 98% specificity versus clinician-collected samples, supporting self-collection as an accurate specimen option.
  5. 5.Centers for Disease Control and Prevention (2024). Screening for Genital Herpes. CDC (cdc.gov/herpes). linkRoutine type-specific serologic herpes screening is not recommended for asymptomatic people, and herpes testing is appropriate when there is a lesion to test.
  6. 6.Centers for Disease Control and Prevention (2024). Human Papillomavirus (HPV). CDC (cdc.gov/hpv). linkHPV is the most common STI and most infections clear on their own, which is why there is no routine HPV screen for most people the way there is for chlamydia or gonorrhea.

6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy

← Back to the health library